Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis.
Yuya Seko Taichiro Nishikawa Atsushi Umemura Kanji Yamaguchi Michihisa Moriguchi Kohichiroh Yasui Mayumi Kimura Hiroaki Iijima Toshio Hashimoto Yoshio Sumida Takeshi Okanoue Yoshito Itoh
Diabetes metabolic syndrome and obesity : targets and therapy
10.2147/DMSO.S184767